Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.

We investigated whether minor histocompatibility (mH) antigen-specific cytotoxic T lymphocytes (CTL) can discriminate between leukemic hematopoietic progenitor cells (leukemic-HPC) from AML or CML patients, the HPC from their remission bone marrow (remission-HPC), and normal HPC from their HLA-ident...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	J Clin Invest
Asıl Yazarlar:	Faber, L M, van der Hoeven, J, Goulmy, E, Hooftman-den Otter, A L, van Luxemburg-Heijs, S A, Willemze, R, Falkenburg, J H
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Clinical Investigation 1995
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185274/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7635982/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI118134
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.

Benzer Materyaller